Drug Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Antibody drug conjugates offer a niche opportunity in drug development and contract manufacturing.

Antibody Drug Conjugates: A Marriage of Biologics and Small Molecules

Nanoparticle-based systems present many advantages for the delivery of current and emerging biological drugs.

Small Wonder: Nanoparticle Strategies for Biological Drugs

Michelle Hoffman, editorial director of Pharmaceutical Technology.

The good, the bad, and the ugly about direct-to-consumer advertising.

Public Service Versus Self-Service

When drugs are encapsulated, electrification (the electrostatic charge of the capsule) may sometimes cause problems, such as capsule adhesion during transportation or dispersion of the capsule content in the filling process.

Creating PVA copolymer capsules

The US Senate approved a measure (HR 2642) that would provide the US Food and Drug Administration with $275 million in additional funding under a supplemental appropriations bill. The measure now goes before the House.

Senate Approves Additional FDA Funding

Also, GVK BIO and Wyeth Pharmaceuticals form research agreement, Eli Lilly announces changes to management, more...

Company and People Notes: Daiichi Sankyo to Acquire U3 Pharma, Somnus Therapeutics Announces Formation of Executive Team, More

The European Federation of Pharmaceutical Industries and Associations (EFPIA), the trade association representing European pharmaceutical manufacturers, issued recommendations to the public consultation launched in March by the European Commission's proposed drug anticounterfeiting measures. EFPIA's proposal includes a ban on drug repackaging.

EFPIA Recommends Drug Anticounterfeiting Measures

Also, Pfizer to close Indiana "Exubera" facility, executive appointments at Patheon, more...

Company and People Notes: Bayer to Remove "Trasylol," Cambrex Appoints Steven M. Klosk president and CEO, More

Also, Quintiles Transnational to acquire Eidetics, ChemAxon appoints Alex Drijver CEO, more...

Company and People Notes: Ranbaxy and Merck to Collaborate, China Biologic Products Appoints Chao Ming Zhao CEO, More

Eli Lilly completed the final and largest phase of a major biotechnology expansion in Indianapolis, Indiana.

Ingredients